If you made any changes in Pure, your changes will be visible here soon.

Research Output 1987 2019

Filter
Article
2019

Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion

Alharbi, A. F., Kratzke, R. A., D’Cunha, J., Maddaus, M. A., Sanghavi, K. J. & Kirstein, M. N., Feb 5 2019, In : Cancer chemotherapy and pharmacology. 83, 2, p. 387-391 5 p.

Research output: Contribution to journalArticle

gemcitabine
Bronchial Arteries
Pharmacokinetics
Metabolites
Intravenous Infusions

Inhibition of oncogenic cap-dependent translation by 4EGI-1 reduces growth, enhances chemosensitivity and alters genome-wide translation in non-small cell lung cancer

De, A., Jacobson, B. A., Peterson, M. S., Stelzner, M. E., Jay-Dixon, J., Kratzke, M. G., Patel, M. R., Bitterman, P. B. & Kratzke, R. A., May 1 2019, In : Cancer gene therapy. 26, 5-6, p. 157-165 9 p.

Research output: Contribution to journalArticle

Eukaryotic Initiation Factor-4F
Non-Small Cell Lung Carcinoma
Genome
Growth
gemcitabine
1 Citation (Scopus)

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models

Patel, M. R., Dash, A., Jacobson, B. A., Ji, Y., Baumann, D., Ismail, K. & Kratzke, R. A., Jan 1 2019, (Accepted/In press) In : Cancer gene therapy.

Research output: Contribution to journalArticle

Oncolytic Virotherapy
Vesicular Stomatitis
Non-Small Cell Lung Carcinoma
Interferons
Viruses
1 Citation (Scopus)

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non–small-cell Lung Cancer

LACE-Bio Steering Committee, Mar 1 2019, In : Clinical Lung Cancer. 20, 2, p. 66-73.e6

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Biomarkers
Immunohistochemistry
Patient Selection
Adjuvant Chemotherapy
2018
2 Citations (Scopus)

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

De, A., Jacobson, B. A., Peterson, M. S., Jay-Dixon, J., Kratzke, M. G., Sadiq, A. A., Patel, M. R. & Kratzke, R. A., Apr 1 2018, In : Investigational New Drugs. 36, 2, p. 217-229 13 p.

Research output: Contribution to journalArticle

Eukaryotic Initiation Factor-4F
Genome
gemcitabine
Pemetrexed
Osteopontin
1 Citation (Scopus)

Asbestos-Related Disease

Kratzke, P. & Kratzke, R. A., Jan 1 2018, (Accepted/In press) In : Journal of Radiology Nursing.

Research output: Contribution to journalArticle

Asbestos
Asbestosis
Mesothelioma
Minerals
Lung Neoplasms
3 Citations (Scopus)

Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer

on behalf of the LACE-Bio Consortium, Jun 1 2018, In : Translational Lung Cancer Research. 7, 3, p. 416-427 12 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Disease-Free Survival
Gene Dosage
Genome
Adjuvant Chemotherapy
1 Citation (Scopus)

Smoking, sex, and non–Small cell lung cancer: Steroid hormone receptors in tumor tissue (S0424)

Cheng, T. Y. D., Darke, A. K., Redman, M. W., Zirpoli, G. R., Davis, W., Ondracek, R. P., Bshara, W., Omilian, A. R., Kratzke, R. A., Reid, M. E., Molina, J. R., Kolesar, J. M., Chen, Y., MacRae, R. M., Moon, J., Mack, P., Gandara, D. R., Kelly, K., Santella, R. M., Albain, K. S. & 1 others, Ambrosone, C. B., Jan 1 2018, In : Journal of the National Cancer Institute. 110, 7, p. 734-742 9 p.

Research output: Contribution to journalArticle

Steroid Receptors
Non-Small Cell Lung Carcinoma
Estrogen Receptors
Smoking
Hormones
12 Citations (Scopus)

Tumor mutation burden as a biomarker in resected non-small-cell lung cancer

Devarakonda, S., Rotolo, F., Tsao, M. S., Lanc, I., Brambilla, E., Masood, A., Olaussen, K. A., Fulton, R., Sakashita, S., McLeer-Florin, A., Ding, K., Le Teuff, G., Shepherd, F. A., Pignon, J. P., Graziano, S. L., Kratzke, R. A., Soria, J. C., Seymour, L., Govindan, R. & Michiels, S., Oct 20 2018, In : Journal of Clinical Oncology. 36, 30, p. 2995-3006 12 p.

Research output: Contribution to journalArticle

Tumor Burden
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Biomarkers
Mutation
2017
4 Citations (Scopus)

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma

Jacobson, B. A., Sadiq, A. A., Tang, S., Jay-Dixon, J., Patel, M. R., Drees, J., Sorenson, B. S., Russell, S. J. & Kratzke, R. A., Jan 1 2017, In : Oncotarget. 8, 38, p. 63096-63109 14 p.

Research output: Contribution to journalArticle

Open Access
Oncolytic Viruses
Measles virus
Virus Diseases
Mesothelioma
Repressor Proteins
6 Citations (Scopus)

Oncolytic viral therapy for mesothelioma

Pease, D. F. & Kratzke, R. A., Aug 24 2017, In : Frontiers in Oncology. 7, AUG, 179.

Research output: Contribution to journalArticle

Mesothelioma
Oncolytic Virotherapy
Therapeutics
Neoplasms
Virus Diseases
24 Citations (Scopus)

Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy

Shepherd, F. A., Lacas, B., Le Teuff, G., Hainaut, P., Jänne, P. A., Pignon, J. P., Le Chevalier, T., Seymour, L., Douillard, J. Y., Graziano, S., Brambilla, E., Pirker, R., Filipits, M., Kratzke, R., Soria, J. C. & Tsao, M. S., Jun 20 2017, In : Journal of Clinical Oncology. 35, 18, p. 2018-2027 10 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Mutation
Disease-Free Survival
Adenocarcinoma
2 Citations (Scopus)

Validation of progression-free survival as a surrogate endpoint for overall survival inmalignant mesothelioma: Analysis of cancer and leukemia group B and north central cancer treatment group (Alliance) trials

Wang, X., Wang, X., Hodgson, L., George, S. L., Sargent, D. J., Foster, N. R., Ganti, A. K., Stinchcombe, T. E., Crawford, J., Kratzke, R., Adjei, A. A., Kindler, H. L., Vokes, E. E. & Pang, H., Feb 10 2017, In : Oncologist. 22, 2, p. 189-198 10 p.

Research output: Contribution to journalArticle

Open Access
Mesothelioma
Disease-Free Survival
Leukemia
Biomarkers
Survival
2016
6 Citations (Scopus)

A 10-Gene Yin Yang Expression Ratio Signature for Stage IA and IB Non-Small Cell Lung Cancer

Xu, W., Jia, G., Davie, J. R., Murphy, L., Kratzke, R. & Banerji, S., Jan 1 2016, In : Journal of Thoracic Oncology. 11, 12, p. 2150-2160 11 p.

Research output: Contribution to journalArticle

Yin-Yang
Non-Small Cell Lung Carcinoma
Genes
Lung Neoplasms
Survival
20 Citations (Scopus)

Detection of occult micrometastases in patients with clinical stage i non-small-cell lung cancer: A prospective analysis of mature results of CALGB 9761 (Alliance)

Martin, L. W., D'Cunha, J., Wang, X., Herzan, D., Gu, L., Abraham, N., Demmy, T. L., Detterbeck, F. C., Groth, S. S., Harpole, D. H., Krasna, M. J., Kernstine, K., Kohman, L. J., Patterson, G. A., Sugarbaker, D. J., Vollmer, R. T., Maddaus, M. A. & Kratzke, R. A., May 1 2016, In : Journal of Clinical Oncology. 34, 13, p. 1484-1491 8 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Non-Small Cell Lung Carcinoma
Immunohistochemistry
Lymph Nodes
Reverse Transcriptase Polymerase Chain Reaction
81 Citations (Scopus)

Prognostic effect of tumor lymphocytic infiltration in resectable non-small-cell lung cancer

Brambilla, E., Le Teuff, G., Marguet, S., Lantuejoul, S., Dunant, A., Graziano, S., Pirker, R., Douillard, J. Y., Le Chevalier, T., Filipits, M., Rosell, R., Kratzke, R. A., Popper, H., Soria, J. C., Shepherd, F. A., Seymour, L. & Tsao, M. S., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1223-1230 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasms
Disease-Free Survival
Survival
Adjuvant Chemotherapy
2015
14 Citations (Scopus)

Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells

Thumma, S. C., Jacobson, B. A., Patel, M. R., Konicek, B. W., Franklin, M. J., Jay-Dixon, J., Sadiq, A., De, A., Graff, J. R. & Kratzke, R. A., Aug 18 2015, In : Cancer gene therapy. 22, 8, p. 396-401 6 p.

Research output: Contribution to journalArticle

Eukaryotic Initiation Factor-4E
Eukaryotic Initiation Factors
Antisense Oligonucleotides
Non-Small Cell Lung Carcinoma
Growth
100 Citations (Scopus)

Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection

Tsao, M. S., Marguet, S., Le Teuff, G., Lantuejoul, S., Shepherd, F. A., Seymour, L., Kratzke, R. A., Graziano, S. L., Popper, H. H., Rosell, R., Douillard, J. Y., Le-Chevalier, T., Pignon, J. P., Soria, J. C. & Brambilla, E. M., Oct 20 2015, In : Journal of Clinical Oncology. 33, 30, p. 3439-3446 8 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Disease-Free Survival
Survival
Proportional Hazards Models
Adenocarcinoma of lung
1 Citation (Scopus)

Targeting topoisomerase II activity in NSCLC with 9-aminoacridine derivatives

Ferguson, D. M., Jacobson, B. A., Jay-Dixon, J., Patel, M. R., Kratzke, R. A. & Raza, A., Jan 1 2015, In : Anticancer Research. 35, 10, p. 5211-5218 8 p.

Research output: Contribution to journalArticle

Aminacrine
Acridines
Type II DNA Topoisomerase
Non-Small Cell Lung Carcinoma
Poisons
12 Citations (Scopus)

Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma

Jacobson, B. A., Chen, E. Z., Tang, S., Belgum, H. S., McCauley, J. A., Evenson, K. A., Etchison, R. G., Jay-Dixon, J., Patel, M. R., Raza, A., Saluja, A. K., D’Cunha, J. & Kratzke, R. A., Jan 1 2015, In : Genes and Cancer. 6, 3-4, p. 144-152 9 p.

Research output: Contribution to journalArticle

Mesothelioma
Prodrugs
Heterografts
Growth
Cell Survival
31 Citations (Scopus)

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

Patel, M. R., Jacobson, B. A., Ji, Y., Drees, J., Tang, S., Xiong, K., Wang, H., Prigge, J. E., Dash, A. S., Kratzke, A. K., Mesev, E., Etchison, R., Federspiel, M. J., Russell, S. J. & Kratzke, R. A., Jan 1 2015, In : Oncotarget. 6, 32, p. 33165-33177 13 p.

Research output: Contribution to journalArticle

Vesicular Stomatitis
Non-Small Cell Lung Carcinoma
Interferons
Viruses
Neoplasms
2014
10 Citations (Scopus)

Measles vaccine strains for virotherapy of non-small-cell lung carcinoma

Patel, M. R., Jacobson, B. A., Belgum, H., Raza, A., Sadiq, A., Drees, J., Wang, H., Jay-Dixon, J., Etchison, R., Federspiel, M. J., Russell, S. J. & Kratzke, R. A., Jan 1 2014, In : Journal of Thoracic Oncology. 9, 8, p. 1101-1110 10 p.

Research output: Contribution to journalArticle

Measles Vaccine
Measles virus
Non-Small Cell Lung Carcinoma
Carcinoembryonic Antigen
Virus Diseases
12 Citations (Scopus)

SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours

Khatri, A., Williams, B. W., Fisher, J., Brundage, R., Gurvich, V. J., Lis, L. G., Skubitz, K. M., Dudek, A. Z., Greeno, E. W., Kratzke, R. A., Lamba, J. K. & Kirstein, M. N., Jan 21 2014, In : British Journal of Cancer. 110, 2, p. 304-312 9 p.

Research output: Contribution to journalArticle

gemcitabine
Pharmacokinetics
Genotype
Neoplasms
Cytidine Deaminase
10 Citations (Scopus)

Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells

Chen, E. Z., Jacobson, B. A., Patel, M. R., Okon, A. M., Li, S., Xiong, K., Vaidya, A. J., Bitterman, P. B., Wagner, C. R. & Kratzke, R. A., Jan 1 2014, In : Investigational New Drugs. 32, 4, p. 598-603 6 p.

Research output: Contribution to journalArticle

Mesothelioma
Protein Biosynthesis
Pemetrexed
Prodrugs
Messenger RNA
2013
4 Citations (Scopus)

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA

Graziano, S. L., Lacas, B., Vollmer, R., Kratzke, R. A., Popper, H., Filipits, M., Seymour, L., Shepherd, F. A., Rosell, R., Veillard, A. S., Taron, M. & Pignon, J. P., Oct 1 2013, In : Lung Cancer. 82, 1, p. 149-155 7 p.

Research output: Contribution to journalArticle

Mucins
Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Histology
Adenocarcinoma
1 Citation (Scopus)
Pleura
Therapeutic Irrigation
Non-Small Cell Lung Carcinoma
Leukemia
Messenger RNA
257 Citations (Scopus)

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

Friboulet, L., Olaussen, K. A., Pignon, J. P., Shepherd, F. A., Tsao, M. S., Graziano, S., Kratzke, R., Douillard, J. Y., Seymour, L., Pirker, R., Filipits, M., André, F., Solary, E., Ponsonnailles, F., Robin, A., Stoclin, A., Dorvault, N., Commo, F., Adam, J., Vanhecke, E. & 8 others, Saulnier, P., Thomale, J., Le Chevalier, T., Dunant, A., Rousseau, V., Le Teuff, G., Brambilla, E. & Soria, J. C., Mar 21 2013, In : New England Journal of Medicine. 368, 12, p. 1101-1110 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
DNA Repair
Protein Isoforms
Antibodies
Cisplatin
30 Citations (Scopus)

Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo

Rousalova, I., Banerjee, S., Sangwan, V., Evenson, K., McCauley, J. A., Kratzke, R. A., Vickers, S. M., Saluja, A. K. & D'Cunha, J., Oct 15 2013, In : PLoS One. 8, 10, e77411.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
carcinoma
apoptosis
lungs
Cells
28 Citations (Scopus)

MiR-1 induces growth arrest and apoptosis in malignant mesothelioma

Xu, Y., Zheng, M., Merritt, R. E., Shrager, J. B., Wakelee, H. A., Kratzke, R. A. & Hoang, C. D., Jan 1 2013, In : Chest. 144, 5, p. 1632-1643 12 p.

Research output: Contribution to journalArticle

MicroRNAs
Apoptosis
Growth
Cell Line
Neoplasms
9 Citations (Scopus)

Phase II study of topotecan and bevacizumab in advanced, refractory non-small-cell lung cancer

Powell, S. F., Beitinjaneh, A., Tessema, M., Bliss, R. L., Kratzke, R. A., Leach, J. & Dudek, A. Z., Sep 1 2013, In : Clinical Lung Cancer. 14, 5, p. 495-501 7 p.

Research output: Contribution to journalArticle

Topotecan
Non-Small Cell Lung Carcinoma
Disease-Free Survival
Salvage Therapy
Poisons
141 Citations (Scopus)

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non–small-cell lung cancer in four trials of adjuvant chemotherapy

Shepherd, F. A., Domerg, C., Hainaut, P., Jänne, P. A., Pignon, J. P., Graziano, S., Douillard, J. Y., Brambilla, E., Le Chevalier, T., Seymour, L., Bourredjem, A., Le Teuff, G., Pirker, R., Filipits, M., Rosell, R., Kratzke, R., Bandarchi, B., Ma, X., Capelletti, M., Soria, J. C. & 1 others, Tsao, M. S., Jun 10 2013, In : Journal of Clinical Oncology. 31, 17, p. 2173-2181 9 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Codon
Mutation
Observation
9 Citations (Scopus)
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Eukaryotic Initiation Factor-4F
Phosphorylation
20 Citations (Scopus)

Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide

Jacobson, B. A., Thumma, S. C., Jay-Dixon, J., Patel, M. R., Dubear Kroening, K., Kratzke, M. G., Etchison, R. G., Konicek, B. W., Graff, J. R. & Kratzke, R. A., Nov 18 2013, In : PloS one. 8, 11, e81669.

Research output: Contribution to journalArticle

gemcitabine
Pemetrexed
mesothelioma
Antisense Oligonucleotides
Mesothelioma
38 Citations (Scopus)
gemcitabine
Guanosine Monophosphate
Lung Neoplasms
Breast Neoplasms
Prodrugs
13 Citations (Scopus)

Yin Yang Gene Expression Ratio Signature for Lung Cancer Prognosis

Xu, W., Banerji, S., Davie, J. R., Kassie, F., Yee, D. & Kratzke, R. A., Jul 17 2013, In : PloS one. 8, 7, e68742.

Research output: Contribution to journalArticle

Yin-Yang
lung neoplasms
Transcriptome
Gene expression
prognosis
2012
57 Citations (Scopus)

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: Analysis of four randomized trials

Reiman, T., Lai, R., Veillard, A. S., Paris, E., Soria, J. C., Rosell, R., Taron, M., Graziano, S., Kratzke, R. A., Seymour, L., Shepherd, F. A., Pignon, J. P. & Sève, P., Jan 1 2012, In : Annals of Oncology. 23, 1, p. 86-93 8 p., mdr033.

Research output: Contribution to journalArticle

Validation Studies
Tubulin
Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Disease-Free Survival
33 Citations (Scopus)

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304

Edelman, M. J., Hodgson, L., Rosenblatt, P. Y., Christenson, R. H., Vokes, E. E., Wang, X. & Kratzke, R. A., Apr 1 2012, In : Journal of Thoracic Oncology. 7, 4, p. 649-654 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Celecoxib
gemcitabine
zileuton
11 Citations (Scopus)
Topoisomerase II Inhibitors
Acridines
Mesothelioma
Cell Proliferation
Apoptosis
11 Citations (Scopus)

Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation

Patel, M. R., Sadiq, A. A., Jay-Dixon, J., Jirakulaporn, T., Jacobson, B. A., Farassati, F., Bitterman, P. B. & Kratzke, R. A., Feb 1 2012, In : International Journal of Oncology. 40, 2, p. 577-582 6 p.

Research output: Contribution to journalArticle

JNK Mitogen-Activated Protein Kinases
Non-Small Cell Lung Carcinoma
Translational Peptide Chain Initiation
Mesothelioma
Intercellular Signaling Peptides and Proteins
19 Citations (Scopus)

Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors

Mitra, A. K., Kirstein, M. N., Khatri, A., Skubitz, K. M., Dudek, A. Z., Greeno, E. W., Kratzke, R. A. & Lamba, J. K., Jul 1 2012, In : Pharmacogenomics. 13, 9, p. 1009-1021 13 p.

Research output: Contribution to journalArticle

gemcitabine
Pharmacogenetics
Pharmacokinetics
Single Nucleotide Polymorphism
Neoplasms
40 Citations (Scopus)

Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report

Dudek, A. Z., Pang, H., Kratzke, R. A., Otterson, G. A., Hodgson, L., Vokes, E. E. & Kindler, H. L., Apr 1 2012, In : Journal of Thoracic Oncology. 7, 4, p. 755-759 5 p.

Research output: Contribution to journalArticle

Leukemia
Macrophage Colony-Stimulating Factor
Neoplasms
Platelet-Derived Growth Factor
Pleural Effusion
153 Citations (Scopus)

Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial

Jänne, P. A., Wang, X., Socinski, M. A., Crawford, J., Stinchcombe, T. E., Gu, L., Capelletti, M., Edelman, M. J., Villalona-Calero, M. A., Kratzke, R., Vokes, E. E. & Miller, V. A., Jun 10 2012, In : Journal of Clinical Oncology. 30, 17, p. 2063-2069 7 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Light
Disease-Free Survival
Non-Small Cell Lung Carcinoma
43 Citations (Scopus)

Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)

Jahan, T., Gu, L., Kratzke, R., Dudek, A., Otterson, G. A., Wang, X., Green, M., Vokes, E. E. & Kindler, H. L., Jun 1 2012, In : Lung Cancer. 76, 3, p. 393-396 4 p.

Research output: Contribution to journalArticle

Leukemia
Disease-Free Survival
Thrombospondin 1
Platelet-Derived Growth Factor
Neoplasms
2011
8 Citations (Scopus)

Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues

Kodali, D., Rawal, A., Ninan, M. J., Patel, M. R., Mesa, H., Knapp, D., Schnitzer, B., Kratzke, R. A. & Gupta, P., Mar 1 2011, In : Archives of Pathology and Laboratory Medicine. 135, 3, p. 365-371 7 p.

Research output: Contribution to journalArticle

Eukaryotic Initiation Factor-4E
Eukaryotic Initiation Factors
B-Cell Lymphoma
Lymphoid Tissue
Lymphoma
55 Citations (Scopus)

Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer

Fujioka, N., Nguyen, J., Chen, C., Li, Y., Pasrija, T., Niehans, G., Johnson, K. N., Gupta, V., Kratzke, R. A. & Gupta, K., Dec 1 2011, In : Anesthesia and Analgesia. 113, 6, p. 1353-1364 12 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Epidermal Growth Factor
Non-Small Cell Lung Carcinoma
Morphine
Opioid Receptors
25 Citations (Scopus)

Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model

Mitra, R., Lee, J., Jo, J., Milani, M., McClintick, J. N., Edenberg, H. J., Kesler, K. A., Rieger, K. M., Badve, S., Cummings, O. W., Mohiuddin, A., Thomas, D. G., Luo, X., Juliar, B. E., Li, L., Mesaros, C., Blair, I. A., Srirangam, A., Kratzke, R. A., McDonald, C. J. & 2 others, Kim, J. & Potter, D. A., May 1 2011, In : Clinical Cancer Research. 17, 9, p. 2934-2946 13 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Gene Expression
Recurrence
Survival
Calcium Channels
130 Citations (Scopus)

Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and leukemia group B trial 30407

Govindan, R., Bogart, J., Stinchcombe, T., Wang, X., Hodgson, L., Kratzke, R. A., Garst, J., Brotherton, T. & Vokes, E. E., Aug 10 2011, In : Journal of Clinical Oncology. 29, 23, p. 3120-3125 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Carboplatin
Non-Small Cell Lung Carcinoma
Leukemia
Thorax
9 Citations (Scopus)

Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and leukemia group B 150304

Edelman, M. J., Hodgson, L., Wang, X., Christenson, R., Jewell, S., Vokes, E. & Kratzke, R. A., Jan 1 2011, In : Journal of Thoracic Oncology. 6, 11, p. 1902-1906 5 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Vascular Endothelial Growth Factor A
Leukemia
Serum
Neoplasms
2010
23 Citations (Scopus)

Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II

Sadiq, A. A., Patel, M. R., Jacobson, B. A., Escobedo, M., Ellis, K., Oppegard, L. M., Hiasa, H. & Kratzke, R. A., Jan 1 2010, In : Investigational New Drugs. 28, 1, p. 20-25 6 p.

Research output: Contribution to journalArticle

Topoisomerase II Inhibitors
Type II DNA Topoisomerase
Cell Line
Inhibitory Concentration 50
Poisons
37 Citations (Scopus)

A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602)

Miller, A. A., Pang, H., Hodgson, L., Ramnath, N., Otterson, G. A., Kelley, M. J., Kratzke, R. A. & Vokes, E. E., Jan 1 2010, In : Journal of Thoracic Oncology. 5, 3, p. 380-384 5 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Leukemia
Neoplasms
Disease-Free Survival
Dasatinib